Home
ADC Summit 2016

SAE Media Group proudly presents the return of the 5th annual ADC Summit to London in 2016!


With the FDA's recent approval of ADC's Adcetris® and Kadcyla ® , the industry has never been moving faster. With around 10 new ADC commercial launches over the coming decade, the report says the overall market will be worth USD 10 billion annually by 2025* and with most ADC research currently only in pre-clinical stages, we are yet to see the full market potential that ADCs are to contribute to the treatment of cancer. In an attempt to develop successors to Adcetris® and Kadcyla ® , the pharmaceutical industry is making every effort to produce the best next generation of ADCs by pioneering new approaches to eliminate cancer stem cells. As a result new innovations in conjugation methods and linker technology are bursting into the clinic at a rapid rate.


The introduction of second wave technology has seen a shift in industry from randomised cross linking technology to site directed technology, which has influenced a number of novel site specific conjugation techniques which have further influenced the next generation of ADCs. SAE Media Group's 5th annual ADC Summit brings you timely discussions to overcome ongoing challenges, including how to improve the therapeutic index of your ADC. Our 2-day event will provide a comprehensive analysis of the various approaches with the next generation ADCs. The conference will also focus on how to screen for optimal site of conjugation and offer some insight into how ADC can work in harmony with the field of oncology.


*http://www.prnewswire.com/news-releases/global-antibody-drug-conjugate-market-outlook-2020-300178206.html
 

sponsors

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Mechanisms of actions

• The range of payload types commercially
available and their mechanism of actions
• Payloads at the discovery or development
stages

David E. Thurston

David E. Thurston, Professor of Drug Discovery, King's College London

Paul Jackson

Paul Jackson, Project Manager, Femtogenix

clock

10:00

Morning Coffee

clock

10:15

Molecular modelling technique

• Molecular modeling approaches to
payload discovery
• Designing maximum cytotoxicity into
payloads

David E. Thurston

David E. Thurston, Professor of Drug Discovery, King's College London

Paul Jackson

Paul Jackson, Project Manager, Femtogenix

clock

11:15

Morning Coffee

clock

11:30

Design and engineering of payloads

• Engineering payloads to not release
prematurely
• Strategies to minimise the hydrophobicity
• Ensuring maximum resistance to
P-glycoprotein pumps in payload design

David E. Thurston

David E. Thurston, Professor of Drug Discovery, King's College London

Paul Jackson

Paul Jackson, Project Manager, Femtogenix

Paul Jackson

Paul Jackson, Project Manager, Femtogenix

clock

12:30

End of workshop

clock

13:30

Registration

Richard Denk

Richard Denk, Head Containment Group, SKAN AG

Martin Glaettli

Martin Glaettli, Sales Engineer , SKAN AG

clock

14:00

What does containment mean for very low

• Containment in low nanogram levels
requires a new approach how to design the
containment and the process
• What technologies are on the market
• How to design the containment for the
API production as well as for the aseptic
processing

Richard Denk

Richard Denk, Head Containment Group, SKAN AG

Martin Glaettli

Martin Glaettli, Sales Engineer , SKAN AG

clock

16:00

Afternoon Tea

clock

16:30

Case study on a low OEL aseptic processing

• Important considerations and parameters
during design of low OEL aseptic processing
• How to combine EHS and GMP
• Final design implementation

Richard Denk

Richard Denk, Head Containment Group, SKAN AG

Martin Glaettli

Martin Glaettli, Sales Engineer , SKAN AG

clock

17:30

End of workshop

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Rakesh Dixit

Rakesh Dixit, Vice President, R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

clock

9:10

Advancement in antibody drug conjugates: A step closer to magic bullets in war against cancer

Rakesh Dixit

Rakesh Dixit, Vice President, R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

• The 5 Rs of ADCs: the right target, the right linker, the right warhead, the right antibody, the right site of conjugation
• Recent developments with site-specific conjugation improving the therapeutic index of ADCs
• Exploring how reducing hydrophobicity of homogeneous ADCs can improve therapeutic index
• Discussing how the stability of the linker  can improve therapeutic index
• Discussing the on and off-target toxicity issues
• Clinical Development of ADCs
 

clock

9:50

Warheads for targeted therapies of cancer: strategies for designing and efficient synthesis of DNA cross-linkers

Iontcho  Vlahov

Iontcho Vlahov, Vice President of Discovery Chemistry, Endocyte, Inc.

• Some DNA cross-linkers are too toxic to be used as antineoplastic agents; instead, they are excellent candidates for the design of ligand-drug conjugates for cancer targeting.
• New concept for design of DNA cross-linkers.
• Efficient total synthesis of cross-linker derivatives for conjugation.
 

clock

10:30

Morning Coffee

clock

11:00

Development of best-in-class, homogeneous ADCs for highly effective and safer cancer therapy

Roger Beerli

Roger Beerli, Chief Scientific Officer, NBE Therapeutics

• Sortase-mediated antibody conjugation (SMAC™): a robust and efficient means to attach toxic payloads to antibodies.
• Highly site-specific conjugation yields homogenous drug product with defined efficacy, PK properties and safety profile.
• Peptide-based linker structure circumvents IP issues and provides superior serum stability.
• In vivo data on lead ADCs generated using site-specific SMAC™-technology will be presented
 

clock

11:40

Preclinical efficacy of a novel anti-C4.4a (LYPD3) antibody drug conjugate BAY 1129980 for the treatment of lung cancer

Joerg Willuda

Joerg Willuda, Senior Scientist, Bayer

• C4.4a (LYPD3) is a novel targeting antigen overexpressed in several cancer indications
• We will present the design of BAY 1129980 employing a novel auristatin
• We will discuss the in vitro and in vivo efficacy profile
• Phase 1 clinical studies are ongoing (NCT02134197)
 

clock

12:20

Networking Lunch

clock

13:30

Producing Better ADCs Using ThioBridge™ Conjugation

Matthew  Bird

Matthew Bird, Bioconjugation Team Leader, Abzena

• Disulfide re-bridging conjugation to reduce ADC heterogeneity
• ThioBridge™ linkers provide stable conjugation
• PK profiles of ThioBridge™ ADCs vs maleimide conjugation
• Development of more efficacious ADCs
 

clock

14:10

Novel site-specific conjugation tools

Thomas Keating

Thomas Keating, Director, Biochemistry, Immunogen, Inc.

• N-terminal serine modification for antibody conjugation: SeriMabs
• Excellent in vitro activity achieved through site-specific conjugation
• Site-specific conjugates are stable and efficacious in vivo
 

clock

14:50

Afternoon Tea

clock

15:20

Expanding the scope of ADC targets through novel conjugation technologies

Sasha Koniev

Sasha Koniev, CEO & Co Founder, Syndivia

• APN linkers with increased serum stability
• New generation of DM1- and MMAE-based payloads
• Expanding the scope of ADC targets by fine-tuning the drug release mechanism
 

clock

16:00

Platform Technologies for Homogeneous and Versatile Protein Modification

Vijay Chudasama

Vijay Chudasama, Lecturer (Organic Chemistry and Chemical Biology), University College London

• Functional disulfide re-bridging
• Controlled dual “click” functionalisation
• Site-selective antibody conjugation
• Photodynamic therapy
• Reversible and irreversible cysteine modification
 

clock

16:40

Chairman’s Closing Remarks and Close of Day One

Rakesh Dixit

Rakesh Dixit, Vice President, R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Mahendra  Deonarain

Mahendra Deonarain, Chief Scientific Officer, Antikor Biopharma Ltd.

clock

9:10

ADCETRIS® (brentuximab vedotin) developed to treat Hodgkin

Ashish Gautam

Ashish Gautam, Global Medical Lead - ADCETRIS, Takeda Pharmaceuticals

• Development of ADCETRIS® - Takeda and Seattle Genetics
alliance
• Exploring the mechanism pathway of ADCETRIS®
• Data published to date from ADCETRIS® registration studies
• Ongoing ADCETRIS® clinical development

clock

9:50

Predicting tissue distribution and clearance of antibody formats to improve selectivity of targeted therapies

Ben-Fillippo  Krippendorff

Ben-Fillippo Krippendorff, Principal Scientist , Roche Pharmaceuticals


• Estimating the tissue distribution of antibodies and antibody fragments based on plasma pharmacokinetics
• Estimation of ADC distribution and tissue specific clearances that influence the therapeutic window
• Optimise biotherapeutic modalities with optimal biodistribution properties to target (and avoid) specific tissues
 

clock

10:30

Morning Coffee

clock

11:00

Impact of drug loading on ADC target binding and cytotoxicity

Debra Meyer

Debra Meyer, Senior Principal Scientist, Pfizer

• Case studies will be presented demonstrating the impact of different levels of drug loading on ADC target binding and cytotoxcity

clock

11:40

Developments in high potency API manufacturing

Richard Denk

Richard Denk, Containment Sales, SKAN AG

  • What does containment mean for very low OEL’s
  • How to design the containment for the
    API production as well as for the aseptic
    processing
  • Case study on a low OEL aseptic processing
    solution
  • clock

    12:30

    Networking Lunch

    clock

    13:30

    Engineering and development of novel immunotargeted nanotherapeutics

    Daryl Drummond

    Daryl Drummond, Vice President, Discovery , Merrimack Pharmaceuticals Inc

    • Engineering considerations for a novel antibody directed nanotherapeutic
    • Target expression and demonstration of targeting
    • Preclinical demonstration of activity and altered tox profile
    • Diagnostic development and clinical trial design for upcoming Phase I
     

    clock

    14:10

    The design, synthesis and scale-up of an ADC tubulysin payload

    Jeremy Parker

    Jeremy Parker, Principal Scientist, AstraZeneca

    • Development of novel ADC payloads based on Tubulysins
    • Identification and development of synthetic routes
    • Scale up of chemistry to deliver material for toxicology and clinical studies
     

    clock

    14:50

    Afternoon Tea

    clock

    15:20

    Challenges and lessons learnt in ADC CMC development and outsourcing

    Jens Lohrmann

    Jens Lohrmann, Senior Global Program Manager, Translational Clinical Oncology, Novartis

    • Buy vs. make: considerations and critical success factors
    • Scale-up and site transfer of a conjugation process with impact on key product quality attributes: case studies
    • Analytical transfers: considerations and lessons learned from a challenging assay transfers
     

    clock

    16:00

    FDCs (Fragment Drug Conjugates): A unique drug class or just smaller ADCs?

    Mahendra  Deonarain

    Mahendra Deonarain, Chief Scientific Officer, Antikor Biopharma Ltd.

    • Using optimised single chain Fvs to obtain high DAR
    • Impact of drug/linker structure on FDC properties
    • Dosing, PK and penetration issues
     

    clock

    16:40

    Chairman’s Closing Remarks and Close of Day Two

    Mahendra  Deonarain

    Mahendra Deonarain, Chief Scientific Officer, Antikor Biopharma Ltd.

    Sponsors and Exhibitors

    Official Media Partner

    Supporters

    Workshops

    ADC Payloads: Availability and Mechanisms of Action

    ADC Payloads: Availability and Mechanisms of Action

    Holiday Inn Kensington Forum
    25 May 2016
    London, United Kingdom

    Preliminary list of attendees - 2016

    Download

    Interview with Mahendra Deonarain

    Download

    Sponsors and Exhibitors


    Abzena

    Sponsors and Exhibitors
    http://www.abzena.com

    Abzena offers a suite of complementary services and technologies. Its range of technologies include immunogenicity assessment, antibody drug conjugation, protein engineering, PEGylation, cell line development , GMP manufacturing and a range of bespoke assays to enables the development of better biopharmaceuticals which will have a greater chance of reaching the market.


    Heraeus

    Sponsors and Exhibitors
    http://www.heraeus-chemicals.com/

    Heraeus’ Business line Pharmaceuticals is the specialist in cytotoxic agents for nearly 30 years. We hold globally a leading position in supply of precious metals based API as well as generic cytotoxic agents Heraeus comprehensive custom services is focused on the synthesis of highly potent compounds (precious metal compounds and small molecules) under high containment conditions and full GMP. In the field of Antibody-Drug-Conjugates our strengths is in payloads. For more details please visit our website www.heraeus-chemicals.com

    Media Partners


    The Pharma Letter

    Official Media Partner
    http://www.thepharmaletter.com/

    The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.


    ADC Review

    Official Media Partner
    http://www.adcreview.com

    ADC Review / Journal of Antibody-drug Conjugates (ISSN: 2327-0152) is an international publication combining professional social media with an online-only, hybrid open-access, peer reviewed journal. The Journal aims to serve the needs of a diverse community of individuals including academia, life sciences, pharma, (basic, translational and clinical) research, clinicians, along with regulatory affairs, government authorities and representatives from payers, and policy makers. Key information includes peer-reviewed articles, news features, discussions, blogs, and a knowledge center offering the latest and most relevant information about Antibody Drug Conjugates (ADCs), BiSpecific Antibodies, Site Specific Antibody Drug Conjugates, Small Molecule Drug Conjugates (SMDC), and Engineered Antibody Fragments. The purpose of the Journal is to present this information in an understandable and a useful format for all stakeholders.


    ecancer

    Official Media Partner
    http://ecancer.org

    ecancer is the leading oncology channel committed to improving cancer communication and education with the goal of optimising patient care and outcomes. By using the latest technologies ecancer works closely with leading figures in oncology to inform and educate the global cancer community.


    WCA Pharma

    Official Media Partner
    http://www.wcapharma.com

    The Members within WCA Pharma all have dedicated personnel fully conversant in the GDP guidelines required for the special handling of Pharmaceutical products. All have the attention to detail required that has seen them become established and recognized by the leading Pharma Industries throughout the world. From Clinical trials, Biotech, Plasma, Laboratory, Health Care, Chilled, Frozen, Controlled Ambient, Packaging, Air, Ocean and Land, you have all Pharmaceutical clusters contained within one exclusive network. Our members are able to pass on their knowledge to clients and use their skills, trust and experience in ensuring all products arrive on time and in the perfect condition. Making sure products are shipped via the correct method, temperature, atmosphere and under controlled conditions ensures these valuable shipments have the care and attention whilst being handled that they deserve.


    BioChem Adda

    Official Media Partner
    https://www.biochemadda.com/

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!

    Media Partners


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    International Journal of Biomedical Engineering and Technology

    Supporters
    http://www.inderscience.com/ijbet

    IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).


    WCA Time Critical

    Supporters
    http://www.wcatimecritical.com





    Bioscreening

    Supporters
    http://www.bioscreening.com



    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    Int. J. of Immunological Studies

    Supporters
    http://www.inderscience.com/ijis

    IJIS publishes a broad range of papers on all aspects of immunology from scientists in academic and non-academic organisations as well as business and government worldwide. IJIS is the flagship journal of the Frontiers in Immunology Research Network.


    Pharmaceutical Business Review

    Supporters
    http://www.pharmaceutical-business-review.com/

    The Business Review websites are your number one stop for all the latest news, comment and industry information. Each Business Review website offers content that is produced by a dedicated team of journalists and global industry experts. It enables you to keep ahead of the latest news relating to your industry. Read independent analysis of the latest issues and developments that affects your business. Target new business leads and Identify potential channels, and benchmark your organisation against others in the industry.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Drug Discovery World

    Supporters
    http://www.ddw-online.com

    For over a decade DDW has continued to be the ‘must read’ journal within the DD&D Arena. DDW is recognised for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised platform for Industry Gurus to debate some of the more challenging technological and business issues facing the the life science industry. DDW adheres to the maxim..... ‘Turning Science into Business’ DDW examines the advances in new technologies and the associated implications within the context of developing new and efficacious therapeutics. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level, allowing both camps to profit from the uncomplicated style of editorial but at the same time challenges our readers to look at new ways to overcome discovery bottlenecks, embrace nascent technologies and build next generation technology platforms.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Thomson Reuters

    Supporters
    http://thomsonreuters.com/products_services/science/

    Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    International Journal of Healthcare Technology and Management

    Supporters
    http://www.inderscience.com/ijhtm

    IJHTM is a series emerging from the International Journal of Technology Management. It provides an international forum and refereed authoritative sources of information in the fields of the economics and management of technology in healthcare.


    Pharmatching.com

    Supporters
    http://pharmatching.com

    Pharmatching.com is an efficient, targeted and easy-to-use-“Web2.0”-tool for finding the right partners in the pharmaceutical industry worldwide. It saves time and costs in all (out)sourcing and business development processes, as it fascilitates and accelerates the searching process for appropriate business partners significantly. Pharmatching.com is particularly advantageous for projects where a special service is (immediately) required or to offer capacities which are currently available. It is useful for services in all categories and stages of drug development including contract manufacturing, contract research, laboratory investigations, contractual testing, non-clinical and clinical research, active pharmaceutical ingredients, consulting, marketing, registration, in- and outlicensing etc.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    AntibodyChain

    Supporters
    http://www.antibodychain.com

    The complete and transparent marketplace for your research antibodies, kits, proteins and small molecules. The sophisticated search engine, with more than 800.000 products, transparency in suppliers, easy comparison, the one stop shop for your research antibodies in combination with interesting news and events plus a CMO exchange makes us a full service partner for you.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Int. J. of Biotechnology

    Supporters
    http://www.inderscience.com/ijbt

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


    British Pharmacological Society

    Supporters
    http://www.bps.ac.uk

    The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry, regulatory agencies and the health services, and many are medically qualified. The Society covers the whole spectrum of pharmacology, including laboratory, clinical, and toxicological aspects. Clinical pharmacology is the medical speciality dedicated to promoting safe and effective use of medicines for patient benefit. Clinical pharmacologists work as consultants in the NHS and many hold prominent positions in UK Universities.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    International Journal of Computational Biology and Drug Design

    Supporters
    http://www.inderscience.com/ijcbdd

    IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Antibodies Online

    Supporters
    http://www.antibodies-online.com

    antibodies-online.com facilitates researchers to find the appropriate antibodies for their respective research project. As an independent and multi-vendor marketplace for research antibodies and thanks to the cooperation with more than 130 different manufacturers, a large selection of Antibodies (over 700,000), ELISA Kits (over 130,000), Secondary Antibodies (17,000), Proteins (130,000), Peptides and Isotype Controls is available. By supporting the Independent Validation Initiative and the Resource Identification Initiative, antibodies-online.com also addresses the important topics of transparent product quality and scientific reproducibility. In addition scientists receive news and detailed information about the individual antibodies from databases such as the PubMed and others.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    International Journal of Environment and Health

    Supporters
    http://www.inderscience.com/ijenvh

    IJEnvH is a fully-refereed scientific journal that provides an international forum for the exchange of information and the advancement of knowledge in the multidisciplinary field of environment and health. The aim of IJEnvH is to stimulate the discussion and communication among scientists, researchers and experts with different background and expertise, involved, at different levels, with the study of environment and health problems.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.